Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Novo Nordisk A/S (NVONy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Novo Nordisk ADR historical data, for real-time data please try another search
58.50 -0.50    -0.85%
05/10 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 58.50 - 58.50
Type:  Equity
Market:  Germany
ISIN:  US6701002056 
S/N:  866931
Novo Nordisk ADR 58.50 -0.50 -0.85%

NYSE:NVONy Financials

 
This summary provides an overview of the most significant critical numbers from each of the Novo Nordisk financial reports, including theNovo Nordis income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NYSE:NVO financials over time via breakdowns of their annual reports.
AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

NVONy Income Statement & Profits

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012
Total Revenue 21380 19983 20962 19845
Gross Profit 17774 16374 17809 16360
Operating Income 8585 7562 7572 7864
Net Income 6734 5982 5755 186.82

NVONy Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012
Total Assets 64289 62447 65669 101648.56
Total Liabilities 28932 28646 25037 92901.42
Total Equity 35357 33801 40632 8747.13

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  56.46%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012
Period Length: 6 Months 3 Months 12 Months 9 Months
Cash From Operating Activities 14353 7070 22214 4942.47
Cash From Investing Activities -253 -393 -4070 -2944.11
Cash From Financing Activities -17788 -10859 -20140 960.81
Net Change in Cash -3699 -4169 -2004 2981.91
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVO Price Commentary

Write your thoughts about Novo Nordisk A/S
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Robin Hood
Guitarman Jan 13, 2022 10:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Despite bullish factors, NVO has moved below its long-term trend, resulting in a Power Gauge rating of Neutral+.
Oc Masai
Oc Masai May 21, 2021 5:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Vote Bullish thanks you NVO management services
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email